We serve Chemical Name:4-(Trifluoromethyl)-4-piperidinol CAS:373603-69-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(Trifluoromethyl)-4-piperidinol
CAS.NO:373603-69-1
Synonyms:4-trifluoromethylpiperidin-4-ol;4-hydroxy-4-tert-butoxycarbonylaminomethylpiperidine;4-hydroxy-4-trifluoromethyl-piperdine;4-hydroxy-4-trifluoromethyl-piperidine
Molecular Formula:C6H10F3NO
Molecular Weight:169.14500
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:32.26000
Exact Mass:169.07100
LogP:0.99200
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-trifluoromethylpiperidin-4-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-hydroxy-4-trifluoromethyl-piperidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-hydroxy-4-trifluoromethyl-piperidine Use and application,4-trifluoromethylpiperidin-4-ol technical grade,usp/ep/jp grade.
Related News: Analysts at Mizuho Americas, who spoke to Lilly’s management this week, said that may well have now changed. “Overall, it sounds like the approval raises new questions for Lilly (as it does for many of us!),” the firm said in a note to clients. 4-(Trifluoromethyl)-4-piperidinol manufacturer J&J, in a statement, confirmed that the FDA authorized the two batches, but did not acknowledge the doses regulators decided should be tossed. 4-(Trifluoromethyl)-4-piperidinol supplier J&J, in a statement, confirmed that the FDA authorized the two batches, but did not acknowledge the doses regulators decided should be tossed. 4-(Trifluoromethyl)-4-piperidinol vendor Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs. 4-(Trifluoromethyl)-4-piperidinol factory Analysts at Mizuho Americas, who spoke to Lilly’s management this week, said that may well have now changed. “Overall, it sounds like the approval raises new questions for Lilly (as it does for many of us!),” the firm said in a note to clients.
